{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:51:43Z","timestamp":1790095903150,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T00:00:00Z","timestamp":1364342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diuretics are among the most commonly prescribed medications and, due to their mechanisms of action, electrolyte disorders are common side effects of their use. In the present work we investigated the associations between diuretics being taken and the prevalence of electrolyte disorders on admission as well as the impact of electrolyte disorders on patient outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this cross sectional analysis, all patients presenting between 1 January 2010 and 31 December 2011 to the emergency room (ER) of the Inselspital, University Hospital Bern, Switzerland were included. Data on diuretic medication, baseline characteristics and laboratory data including electrolytes and renal function parameters were obtained from all patients. A multivariable logistic regression model was performed to assess the impact of factors on electrolyte disorders and patient outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 8.5% of patients presenting to the ER used one diuretic, 2.5% two, and 0.4% three or four. In all, 4% had hyponatremia on admission and 12% hypernatremia. Hypokalemia was present in 11% and hyperkalemia in 4%. All forms of dysnatremia and dyskalemia were more common in patients taking diuretics. Loop diuretics were an independent risk factor for hypernatremia and hypokalemia, while thiazide diuretics were associated with the presence of hyponatremia and hypokalemia. In the Cox regression model, all forms of dysnatremia and dyskalemia were independent risk factors for in hospital mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Existing diuretic treatment on admission to the ER was associated with an increased prevalence of electrolyte disorders. Diuretic therapy itself and disorders of serum sodium and potassium were risk factors for an adverse outcome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1741-7015-11-83","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T01:14:21Z","timestamp":1364346861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Impact of diuretic therapy-associated electrolyte disorders present on admission to the emergency department: a cross-sectional analysis"],"prefix":"10.1186","volume":"11","author":[{"given":"Spyridon","family":"Arampatzis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg-Christian","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Benedikt","family":"Leichtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg-Martin","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristomenis Konstantinos","family":"Exadaktylos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,27]]},"reference":[{"key":"722_CR1","volume-title":"Clinical Physiology of Acid\u2013base and Electrolyte Disorders","author":"BD Rose","year":"2001","unstructured":"Rose BD, Post TW: Clinical use of diuretics. Clinical Physiology of Acid\u2013base and Electrolyte Disorders. 2001, New York, NY: McGraw Hill, Volume 15 5","edition":"Volume 15 5"},{"key":"722_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1751-7176.2008.08126.x","volume":"10","author":"SJ Mann","year":"2008","unstructured":"Mann SJ: The silent epidemic of thiazide-induced hyponatremia. J Clin Hypertens (Greenwich). 2008, 10: 477-484.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"722_CR3","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1093\/ndt\/gfi109","volume":"20","author":"P Gross","year":"2005","unstructured":"Gross P, Palm C: Thiazides: do they kill?. Nephrol Dial Transplant. 2005, 20: 2299-2301.","journal-title":"Nephrol Dial Transplant"},{"key":"722_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1001\/jama.1992.03480080053026","volume":"267","author":"D Siegel","year":"1992","unstructured":"Siegel D, Hulley SB, Black DM, Cheitlin MD, Sebastian A, Seeley DG, Hearst N, Fine R: Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 1992, 267: 1083-1089.","journal-title":"JAMA"},{"key":"722_CR5","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.amjmed.2011.06.031","volume":"124","author":"AA Leung","year":"2011","unstructured":"Leung AA, Wright A, Pazo V, Karson A, Bates DW: Risk of thiazide-induced hyponatremia in patients with hypertension. Am J Med. 2011, 124: 1064-1072.","journal-title":"Am J Med"},{"key":"722_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2125.2005.02531.x","volume":"61","author":"JA Clayton","year":"2006","unstructured":"Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP: Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol. 2006, 61: 87-95.","journal-title":"Br J Clin Pharmacol"},{"key":"722_CR7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1445-5994.2010.02217.x","volume":"40","author":"DS Shapiro","year":"2010","unstructured":"Shapiro DS, Sonnenblick M, Galperin I, Melkonyan L, Munter G: Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome. Intern Med J. 2010, 40: 574-580.","journal-title":"Intern Med J"},{"key":"722_CR8","volume-title":"Clinical Physiology of Acid\u2013base and Electrolyte Disorders","author":"BD Rose","year":"2001","unstructured":"Rose BD: Clinical Physiology of Acid\u2013base and Electrolyte Disorders. 2001, New York, NY: McGraw-Hill, 5","edition":"5"},{"key":"722_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-009-1692-0","volume":"36","author":"GC Funk","year":"2010","unstructured":"Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, Metnitz PG: Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010, 36: 304-311.","journal-title":"Intensive Care Med"},{"issue":"2","key":"722_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-009-1692-0","volume":"36","author":"G Lindner","year":"2010","unstructured":"Lindner G, Funk GC, Lassnigg A, Mouhieddine M, Ahmad SA, Schwarz C, Hiesmayr M: Intensive care-acquired hypernatremia after major cardiothoracic surgery is associated with increased mortality. Intensive Care Med. 2010, 36 (2): 304-311.","journal-title":"Intensive Care Med"},{"key":"722_CR11","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1053\/j.ajkd.2007.08.016","volume":"50","author":"G Lindner","year":"2007","unstructured":"Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, Kramer L, Druml W: Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007, 50: 952-957.","journal-title":"Am J Kidney Dis"},{"key":"722_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2011.1967","volume":"307","author":"A Goyal","year":"2012","unstructured":"Goyal A, Spertus JA, Gosch K, Venkitachalam L, Jones PG, Van den Berghe G, Kosiborod M: Serum potassium levels and mortality in acute myocardial infarction. JAMA. 2012, 307: 157-164.","journal-title":"JAMA"},{"issue":"8","key":"722_CR13","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/jbmr.380","volume":"26","author":"EJ Hoorn","year":"2011","unstructured":"Hoorn EJ, Rivadeneira F, van Meurs JB, Ziere G, Stricker BH, Hofman A, Pols HA, Zietse R, Uitterlinden AG, Zillikens MC: Mild hyponatremia as a risk factor for fractures: the Rotterdam Study. J Bone Miner Res. 2011, 26 (8): 1822-1828.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"722_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2215\/CJN.06120809","volume":"5","author":"S Kinsella","year":"2010","unstructured":"Kinsella S, Moran S, Sullivan MO, Molloy MG, Eustace JA: Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol. 2010, 5 (2): 275-280.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"722_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.5301\/jn.5000064","volume":"25","author":"R Tolouian","year":"2012","unstructured":"Tolouian R, Alhamad T, Farazmand M, Mulla ZD: The correlation of hip fracture and hyponatremia in the elderly. J Nephrol. 2012, 25 (5): 789-793.","journal-title":"J Nephrol"},{"key":"722_CR16","first-page":"913","volume":"14","author":"K Lenz","year":"1986","unstructured":"Lenz K, Gossinger H, Laggner A, Druml W, Grimm G, Schneeweiss B: Influence of hypernatremic-hyperosmolar state on hemodynamics of patients with normal and depressed myocardial function. Crit Care Med. 1986, 14: 913-914.","journal-title":"Crit Care Med"},{"key":"722_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0140-6736(98)85044-7","volume":"352","author":"ML Halperin","year":"1998","unstructured":"Halperin ML, Kamel KS: Potassium. Lancet. 1998, 352: 135-140.","journal-title":"Lancet"},{"key":"722_CR18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.V541106","volume":"5","author":"BA Clark","year":"1994","unstructured":"Clark BA, Shannon RP, Rosa RM, Epstein FH: Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol. 1994, 5: 1106-1111.","journal-title":"J Am Soc Nephrol"},{"key":"722_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/qjmed\/hcg157","volume":"96","author":"KM Chow","year":"2003","unstructured":"Chow KM, Szeto CC, Wong TY, Leung CB, Li PK: Risk factors for thiazide-induced hyponatraemia. QJM. 2003, 96: 911-917.","journal-title":"QJM"},{"key":"722_CR20","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.amjmed.2005.09.026","volume":"119","author":"B Renneboog","year":"2006","unstructured":"Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G: Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006, 119: e71-78.","journal-title":"Am J Med"},{"key":"722_CR21","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","volume":"371","author":"G Decaux","year":"2008","unstructured":"Decaux G, Soupart A, Vassart G: Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet. 2008, 371: 1624-1632.","journal-title":"Lancet"},{"key":"722_CR22","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1056\/NEJMoa065181","volume":"355","author":"RW Schrier","year":"2006","unstructured":"Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C: Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006, 355: 2099-2112.","journal-title":"N Engl J Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-11-83\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-83","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:54:15Z","timestamp":1630536855000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-11-83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,27]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-11-83","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,27]]},"assertion":[{"value":"17 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"83"}}